Clinical Trial Update: The Efficacy of the Longeviti ClearFit Implant in Craniectomies for Post-Operative Monitoring in Chronic Subdural Hematomas [NA]

View source ↗

Summary

A clinical trial evaluating the Longeviti ClearFit Implant for post-operative monitoring in chronic subdural hematoma patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• Longeviti ClearFit Implant

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Chronic Subdural Hematoma | NA | Status: WITHDRAWN